Evidence map›Paper›PMID 38888699›Full record

ArticleApplied biochemistry and biotechnology2024

LncRNA OIP5-AS1 Upregulates the Cyclin D2 Levels to Promote Metastasis of Breast Cancer by Targeting miR-150-5p.

Heming Wu, Qingyan Huang, Tai Xu, Jinfeng Zhang, Juanzi Zeng, Qiuming Wang, Yunuo Zhang, Zhikang Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Potential regulatory role of the mActa biochimica et biophysica Sinica · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Heming WuCenter for Precision Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Qingyan HuangCenter for Precision Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Tai XuDepartment of Breast Surgery, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Jinfeng ZhangDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Juanzi ZengDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Qiuming WangDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Yunuo ZhangDepartment of Medical Oncology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China.
Zhikang YuCenter for Precision Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China. yuzhikang01@126.com.

Funding

the Basic and Applied Basic Research Foundation of Guangdong Province 2021A1515220106the Science and Technology Program of Meizhou 2019B0202001the Scientific Research Cultivation Project of Meizhou People's Hospital PY-C2020020the Scientific Research Cultivation Project of Meizhou People's Hospital PY-C2020031the Scientific Research Cultivation Project of Meizhou People's Hospital PY-C2020033the Scientific Research Cultivation Project of Meizhou People's Hospital PY-C2021051
6 · The paper itself

Abstract

objectiveBreast cancer (BC) is a cancer that seriously affects women's health. BC cell migration increases the mortality of BC patients. Current studies have shown that long noncoding RNAs (LncRNAs) are related to the metastasis mechanism of BC. This study aimed to explore the function and role of LncRNA OIP5-AS1 in BC. And we analyzed its regulatory mechanism and related modification process.

methodsOur study analyzed the expression pattern of OIP5-AS1 in BC tissues and cell lines by qRT-PCR. The effects of OIP5-AS1 on the function of BC cells were detected by CCK-8 and transwell experiments. Bioinformatics analysis and double luciferase reporter gene detection were used to confirm the correlation between OIP5-AS1 and miR-150-5p and between miR-150-5p and Cyclin D2 (CCND2). The rescue test analyzed the effect of miR-150-5p regulating OIP5-AS1. In addition, the N

resultsOIP5-AS1 was significantly upregulated in BC tissues and cell lines. OIP5-AS1 knockdown inhibited BC cell viability, migration and invasion. OIP5-AS1 upregulated CCND2 by binding with miR-150-5p. This process affected the metastasis of BC. Higher degree of m

conclusionsLncRNA OIP5-AS1 promoted cell viability and metastasis of BC cells by targeting miR-150-5p/CCND2 axis. This process was modified by m

Indexed as

Breast NeoplasmsCell MovementCyclin D2MicroRNAsRNA, Long NoncodingUp-RegulationAdenosineCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMCF-7 CellsNeoplasm MetastasisAdenosineCCND2 protein, humanCyclin D2long noncoding RNA OIP5, humanMicroRNAsMIR150, humanN-methyladenosineRNA, Long NoncodingBreast cancerCCND2LncRNA OIP5-AS1m6AMETTL3miR-150-5p

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.